Manidipine: a review of its use in the management of hypertension.
暂无分享,去创建一个
[1] A. Semplicini,et al. Effect of Manidipine on Gene Expression and Protein Level of Oxidative Stress-Related Proteins: p22phox and HO-1: Relevance for Antihypertensive and Anti-Remodeling Effects , 2004, Journal of cardiovascular pharmacology.
[2] F. Locatelli,et al. Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril. , 2004, Journal of nephrology.
[3] M. Hosono,et al. Orally administered benidipine and manidipine prevent ischemia-reperfusion injury in the rat heart. , 2004 .
[4] E. Johns. Smoking is bad for you: our genes say so! , 2004, Journal of hypertension.
[5] S. Mochizuki,et al. Effects of efonidipine, an L- and T-Type dual calcium channel blocker, on heart rate and blood pressure in patients with mild to severe hypertension: an uncontrolled, open-label pilot study. , 2003, Current therapeutic research, clinical and experimental.
[6] J. Kostis. Treatment of hypertension in older patients: an updated look at the role of calcium antagonists. , 2003, The American journal of geriatric cardiology.
[7] T. Saruta,et al. Role of Actions of Calcium Antagonists on Efferent Arterioles – with Special References to Glomerular Hypertension , 2003, American Journal of Nephrology.
[8] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[9] K. Harada,et al. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities. , 2003, Circulation journal : official journal of the Japanese Circulation Society.
[10] G. Mazzaglia,et al. Effects of Manidipine and Nifedipine on Blood Pressure and Renal Function in Patients with Chronic Renal Failure: A Multicenter Randomized Controlled Trial , 2003, Renal failure.
[11] F. Veglio,et al. Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study , 2002, Journal of hypertension.
[12] C. Ram. Usefulness of lercanidipine, a new calcium antagonist, for systemic hypertension. , 2002, The American journal of cardiology.
[13] Artur Beltrame Ribeiro,et al. Manidipina no tratamento da hipertensão arterial essencial estágio I e II do paciente com sobrepeso ou obesidade andróide. Estudo multicêntrico brasileiro de eficácia, tolerabilidade e efeitos metabólicos , 2001 .
[14] A. Zanchetti,et al. Efficacy, Tolerability, and Impact on Quality of Life of Long-Term Treatment with Manidipine or Amlodipine in Patients with Essential Hypertension , 2001, Journal of cardiovascular pharmacology.
[15] R. Fogari,et al. Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension , 2000, Journal of hypertension.
[16] Thomas Hedner,et al. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study , 2000, The Lancet.
[17] G Mancia,et al. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients. , 2000, Journal of cardiovascular pharmacology.
[18] T. Ogihara. Practitioner's Trial on the Efficacy of Antihypertensive Treatment in the Elderly Hypertension (The PATE-Hypertension Study) in Japan. , 2000, American journal of hypertension.
[19] H. Yamazaki,et al. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug–drug interactions , 2000, European Journal of Clinical Pharmacology.
[20] Y. Iwamoto,et al. Delapril versus manidipine in hypertensive therapy to halt the type-2-diabetes-mellitus-associated nephropathy. , 2000, Diabetes research and clinical practice.
[21] R. Fogari,et al. Effect of Low-Dose Manidipine on Ambulatory Blood Pressure in Very Elderly Hypertensives , 1999, Cardiovascular Drugs and Therapy.
[22] M. Nagase,et al. LONG‐TERM EFFECT OF MANIDIPINE ON RENAL FUNCTION AND STRUCTURE IN UNINEPHRECTOMIZED SPONTANEOUSLY HYPERTENSIVE RATS , 1997, Clinical and experimental pharmacology & physiology.
[23] M. Hayakawa,et al. Effect of Dihydropyridine Calcium Channel Blockers on the Plasma Digoxin Level , 1996 .
[24] Y. Hinokio,et al. Effect of manidipine and delapril on insulin sensitivity in type 2 diabetic patients with essential hypertension. , 1996, Diabetes research and clinical practice.
[25] Y. Miyazaki,et al. Effects of a calcium channel blocker, manidipine, on insulin sensitivity in essential hypertensives. , 1995, Journal of diabetes and its complications.
[26] A. Hishida,et al. Effects of a calcium antagonist, manidipine, on progressive renal injury associated with mild hypertension in remnant kidneys. , 1995, The Journal of laboratory and clinical medicine.
[27] J. Tsai,et al. Effects of manidipine hydrochloride on blood pressure in hypertensive patients--a comparison with nifedipine retard. , 1993, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences.
[28] T. Saruta,et al. Efficacy of manidipine in the treatment of hypertension with renal impairment: a multicenter trial. , 1993, American heart journal.
[29] A. Luger,et al. An evaluation of the renal protective effect of manidipine in the uninephrectomized spontaneously hypertensive rat. , 1993, American heart journal.
[30] Å. Wennmalm. Nitric oxide (NO) in the cardiovascular system. Some physiological and evolutionary aspects. , 1992, Blood pressure.
[31] T. Kitayoshi,et al. Calcium channel blocking action of franidipine hydrochloride (CV-4093.2HCl) in vitro and in vivo. , 1988, Japanese journal of pharmacology.
[32] Y. Hattori,et al. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists. , 1988, European journal of pharmacology.
[33] T. Sasaki,et al. Renal effects of manidipine hydrochloride , 2004, European Journal of Clinical Pharmacology.